Home › Post-Traumatic Stress Disorder › NCT07759882

Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Able to write, understand, and speak English
* Able to give informed consent
* Currently pregnant or postpartum (≤ 6 months after childbirth)
* History of substance misuse
* Receiving services for substance-use related problems
* Have a history of traumatic event exposure
* Endorse clinically significant PTSD symptoms (score ≥ 3 on the Primary Care PTSD Screen for DSM-5; PC-PTSD-5)

Exclusion Criteria:

* Unwilling to provide consent
* No history of Criterion A trauma exposure or clinically significant PTSD symptoms
* No history of substance misuse or currently receiving services for a substance-use related problem

About the study

The goal of this study is to examine the feasibility and acceptability of providing Written Exposure Therapy (WET), a brief, evidence-based therapy for post-traumatic stress disorder (PTSD) via tele-health to pregnant and postpartum individuals receiving services for problematic substance misuse in Arkansas.

What is being tested

• Written Exposure Therapy (WET) (behavioral)

Sponsor: University of Arkansas · Participants: 80 · Started: Sep 1, 2026

Contact the study team

• Mollee K. Steely Smith K Assistant Professor, PhD · Phone: 501-526-8174

Official record on ClinicalTrials.gov — NCT07759882

Locations in the U.S.

Conditions

• Post-Traumatic Stress Disorder

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.